Cookies disclaimer
By continuing your browsing, you accept the deposit of third-party cookies for audience measurement (Google Analytics), to offer you share buttons, social content downloads.
I AGREE
I REFUSE

ALTIOS Corporate Finance supports PROTEX International in the acquisition of the US company Greenfield Manufacturing Inc. (GMI)

Press Release - May 2024

An acquisition allowing PROTEX International to expand its activities in the US market.

In May 2024, the shareholders of Protex International, Mr. Robert Moor and his family, an independent French company specialized in manufacturing niche chemicals, has acquired 100% of Greenfield Manufacturing Inc., a US manufacturer of specialty chemicals.

Greenfield Manufacturing Inc. is an industrial company specializing in chemicals manufacturing, founded by Duane Palmateer, and based in Saratoga Springs, NY.

The Protex International group is offering services to ensure the development, manufacturing, and distribution of specialty chemicals additives for a wide range of sectors.

This acquisition strengthens the position of Protex and its US subsidiaries (Protavic America) in the US market with now 2 locations.

The Protex International group has a long history of commitment to innovation and quality in the field of specialty chemicals. With its strong family values, the group shares with GMI a common passion for innovation, and customer satisfaction.

A transaction supported by Altios Corporate Finance

The role of Altios Corporate Finance was to support Protex International group in its M&A strategy in the US. The mandate involved several steps, from identifying companies that complement Protex International group in terms of geography and business lines, contacting the relevant targets, carrying out a financial analysis of these targets, and finally assisting the group through the negotiations and due diligence phases up to closing.

The role of Altios Corporate Finance:

  • Screening of the US market
  • Approach the qualified targets
  • Financial analysis and valuation of the target company
  • Due diligence coordination
  • Support in negotiating LOI, SPA & other transactional documents

Testimony of Protex International

The common values shared by GREENFIELD MANUFACTURING Inc. and PROTEX INTERNATIONAL - commitment to innovation and constructive relationships with our American customers - will ensure a smooth integration and maximize synergies

Robert Moor, CEO and Chairman – Protex International

Testimony of Altios Corporate Finance

We are pleased to have finalized this deal enabling Protex to strengthen its presence in the US. The similar values with GMI and its focus in specialty chemical products will ensure a smooth integration and maximize the synergies.

Alexandre Kaplan, M&A Director – Altios Corporate Finance

Participants

Buyer’s advisors:

  • Altios Corporate Finance (M&A): Alexandre Kaplan, Camille Garbolino and Nicolas Vacher
  • Mirick O’Connell (Legal): David E. Surprenant and Andrew A. Croxford
  • Shaheen, Pallone & Associates (Financial / CPA): Bill Shaheen Sr. and Bill Shaheen

Sellers’ advisors:

  • Independent (Legal): William W. Dailey
  • Independent (Financial / CPA): Rebecca J. Herrick

Contact Press: Alexandre Kaplan, M&A Director, a.kaplan@altios.com

Protex international x Greenfield

ALTIOS Corporate Finance supports Oncodesign Services in the acquisition of the Dutch company ZoBio

Press Release – January 2024

A Strategic Acquisition in the Netherlands, strengthening Oncodesign Services' Position in Small Molecule Drug Discovery

Oncodesign Services, a French Preclinical Drug Discovery company, has completed the acquisition of the
Dutch company ZoBio expert in biophysics-based Small Molecule Drug Discovery.

Oncodesign Services is a leading European CRO in preclinical drug discovery. The company supports its
biotech and pharmaceutical customers in the preclinical evaluation of experimental therapies in oncology
and immuno-inflammation, drawing on its expertise in medicinal chemistry, computational chemistry,
DMPK, pharmaco-imaging, and molecular radiotherapy. The company has successfully developed several
drug candidates that have reached the clinical development phase together with its partner clients. Since
January 2023, the funds advised by Elyan Partners have been the majority shareholder in Oncodesign
Services.

ZoBio is a Dutch player specializing in the early stages of preclinical research on small molecules. ZoBio
has built a class-leading platform that provides a complete solution for Fragment Based Drug Discovery
to their clients. Their gene-to-lead capabilities include protein production, biophysical and functional
assays, structural biology (crystallography, NMR & cryoEM), and fragment-focused medicinal chemistry.

The acquisition of ZoBio strengthens Oncodesign Services in the upstream phase of Drug Discovery to
form a European player offering integrated drug candidate discovery services, specializing in small
molecules. The combined entities generated nearly €44m in sales in 2023 and have over 280 employees
spread between France, the Netherlands, and with subsidiaries in Canada and the USA.

Oncodesign Services aims to become a European leader in Drug Discovery, by offering integrated services,
placing operational excellence at the heart of its strategy, and investing in innovative technologies.

In conjunction with this transaction, Nov Santé Actions Non Cotées, managed by Eurazeo, is investing in
Oncodesign Services, thereby increasing the resources available to finance external growth and giving the
Company the benefit of its expertise as an investor specializing in Life Sciences.

A transaction led by Altios Corporate Finance

  • Altios Corporate Finance advised and supported Oncodesign Services in its external growth strategy. The mandate included identifying companies with a geographical and technological fit with Oncodesign Services, making contact with relevant targets, analyzing ZoBio’s strategic and commercial positioning, and then providing support during the negotiation and due diligence coordination phases.
  • Altios Corporate Finance’s role:
    • Screening, market research, identification, and qualification of potential acquisition targets in several countries
    • Approach of qualified targets
    • Coordination of due diligence, including commercial due diligence (customer interviews)
    • Analysis of customer satisfaction and service quality.

With this transaction, Altios Corporate Finance confirms its ability to support its clients in complex operations and bring strategic cross-border transactions to a successful conclusion.

  • Altios Corporate Finance confirms its positioning as a buy-side M&A advisor in international small & mid cap external growth transactions.
  • Altios also demonstrates its ability to forge long-term relationships with its customers, enabling it to provide support that is as close as possible to the strategic capital-intensive challenges facing companies, in conjunction with the Crédit Agricole Group and in particular the Champagne Bourgogne Regional Bank, which helped establish the business relationship with Oncodesign Services 3 years ago.

Testimony of Oncodesign Services

We are delighted to welcome ZoBio to the Group, strengthening our offering of preclinical small molecule drug discovery services, from therapeutic target to clinical entry, thanks to leading-edge skills and technologies. Oncodesign Services and ZoBio are highly complementary, and we share the same ambition of working together to identify innovative new drug candidates for our customers in major therapeutic areas. I would like to extend my warmest thanks to our partners at Altios, Elyan Partners, Eurazeo, and my management team for their excellent support in this acquisition, which is an important and transforming first step in the Group's development strategy

Fabrice Viviani, CEO – Oncodesign Services

Testimony of Elyan Partners

The acquisition of ZoBio reflects the ambition we share with the management team of Oncodesign Services to build a European leader in preclinical services. It is a strategic move for Oncodesign Services, which acquires the expertise needed to develop an integrated offering from therapeutic target to regulatory preclinical stage. It will also enable the Group to accelerate its growth and internationalization through ZoBio's strong presence in North America from its base in the Netherlands, combined with Oncodesign Services' excellent positioning in Europe.

Jean-François Félix & Maxence de Vienne, Partners – Elyan Partners

Testimony of Altios Corporate Finance

We are delighted to have been able to bring about this value-creating merger for the Oncodesign Services group, which will continue its international expansion to become a European leader in preclinical services. Our close and trusting relationship with the management of Oncodesign Services and the Elyan Partners teams has enabled us to complete this transaction under the best possible conditions.

Alexandre Kaplan, M&A Director and Partner – Altios Corporate Finance

Participants

Buyer’s advisors:
Altios Corporate Finance (M&A) : Alexandre Kaplan, Elia Laurent, Nicolas Vacher
➢ Financial : FTI Bold – Saskia Hinkenkemper, Arnoud Hattink, Anne van der Giessen, Arthur Oomen
➢ Legal : McDermott Will & Emery – Henri Pieyre de Mandiargues, Côme de Saint-Vincent, Lucie Martin, Natacha Vasak
➢ Legal : DeBreij – Gaston Freijser, Robert Vodegel, Maxime Jongh
➢ Fiscal : VanLoman – Marc Oostenbroek, Lotte van Rij, Maiken Rooker, Daniël Pieters
➢ ESG : ERM – Maryelle Ouvrard, Aurélien Beckmann, Siena Schickler

Contact Press: Alexandre Kaplan, M&A Director, a.kaplan@altios.com

What are the advantages of the Australian market?

Advantages of the Australian Market - Photo

December 2023

Australia has a stable and diversified economy, from robust mining and agricultural sectors to growing expertise in technology industries. Its strategic geographic position makes it a key player in international trade, with close commercial links with Asia-Pacific and the Middle East.

In this article, ALTIOS’ experts share how foreign companies can take advantage from what Australia has to offer.

Australia's Economic Excellence

Considered as a model of economic stability, Australia boasts a resilient economy, characterised by steady GDP growth and remarkably low inflation rates. Despite global economic challenges, Australia has maintained robust GDP growth, averaging an impressive 2-3% per year, renforcing its status as an attractive investment destination.

Australia is distinguished by the diversification of its economy, covering key sectors such as mining, agriculture, services and technology. This diversification not only promotes resilience, but also reduces dependence on any single sector. With services accounting for around 60% of Australia’s GDP, alongside significant contributions from mining, manufacturing and agriculture, Australia’s economic landscape offers a wealth of investment opportunities.

Australia’s stable and well-regulated financial sector, which accounts for more than 8% of GDP, is also a key pillar of this economic success. This strength enhances the overall attractiveness to international investors seeking a safe and prosperous market.

In navigating the global business landscape, Australia stands as a strategic partner, providing a stable platform for growth, diverse investment opportunities, and the assurance of a well-regulated financial environment.

A global innovation hotspot

Australia is swiftly solidifying its position as a global innovation hub, drawing substantial investments in research and development. With an annual allocation exceeding $10 billion, the nation is propelling technological advancements and fostering an environment conducive to innovation. This commitment, one of the big advantages of the Australian market, positions it as an ideal destination for businesses seeking to thrive on the forefront of cutting-edge technologies.

Complementing this innovation drive is Australia’s robust commitment to infrastructure development. Ongoing investments, exemplified by the $110 billion National Infrastructure Plan, are strategically enhancing connectivity across transport, energy, and digital sectors. These developments not only bolster economic growth but also streamline operations for companies, creating a seamless environment for international enterprises to operate efficiently and prosper. Australia’s fusion of innovation and infrastructure lays the groundwork for a dynamic and forward-looking business landscape.

A winning combination of good education and quality of life

Australia presents a compelling proposition for international expansion, combining a highly educated and skilled workforce with an exceptional quality of life. With approximately 40% of Australians aged 25-34 holding tertiary qualifications, the country stands as an ideal destination for companies in search of top-tier talent and expertise.

Beyond professional considerations, Australia offers an unparalleled quality of life, making it an attractive haven for professionals and their families. Renowned cities like Melbourne and Sydney consistently rank among the world’s most livable, contributing to an elevated quality of life that goes hand-in-hand with the opportunities for professional growth. The synergy of a skilled workforce and an exceptional quality of life positions Australia as a strategic choice for businesses aiming to expand internationally.

Advantages of the Australian Market - Melbourne

The "Land Down Under"

Australia emerges as a pivotal player for international expansion, strategically positioned as a gateway to the dynamic Asia-Pacific region. With a geographic location that provides unparalleled access to a market exceeding 4.5 billion people, businesses can capitalize on Australia’s unique position to tap into the vast and growing opportunities within the Asia-Pacific market.

In addition to these strategic advantages of the Australian market, Australia has an abundance of natural resources, a cornerstone of its economic strength. Boasting a leadership role as a global exporter of resources such as coal, iron ore, gold, and agricultural products, the country becomes not only a gateway to markets but also a source of valuable resources for industries worldwide. We therefore advise you to make the most of Australia’s strategic location and resource-rich landscape, unlocking the full spectrum of opportunities for your business.

Australia's Pillars of Trade and Stability

Australia emerges as an international business hub, underpinned by robust trade relationships and unwavering political stability. The country’s strong trade ties with global economic powerhouses, including China, Japan, and South Korea, are facilitated by free trade agreements, creating an advantageous environment for international business activities.

Beyond commerce, Australia is distinguished by its political stability and transparent governance, laying the foundation for a favorable business environment. Consistently ranking high in global indices for political stability and transparency, Australia provides businesses with the confidence and security needed to thrive in the international arena.

Would you like to go further and develop your business in Australia?

Season's Greetings 2024!

The ALTIOS teams around the world wish you all the best and a wonderful year 2024!

Let’s work together to make this year exceptional, prosperous, and responsible!

We look forward to working with you to achieve your goals in 2024.

Discover our Season's Greetings' video!

ALTIOS Corporate Finance supports RAGNI in the acquisition of the German company HESS GmbH LICHT + FORM

Press Release – December 2023

An acquisition allowing RAGNI to Expand its activities internationally

  • In June 2023, the shareholders of Ragni, a French company offering design and manufacture of public lighting solutions, through its RAGNI brands, NOVEA ENERGIES and SEVⓔ brands, decided to acquire 100% of Hess GmbH Licht + Form, subsidiary of Nordeon Holding GmbH and Experience Brands S.a.r.l., an international manufacturer of designed outdoor luminaires and site furnishings.

  • Nordeon Holding GmbH (newly renamed Experience Brands) is an industrial group specializing in lighting. The group comprises the Nordeon, Vulkan and Hess brands. Hess GmbH and Hess USA, respectively for their areas of activities (Hess GmbH on the European market), have been acquired by Nordeon in 2013, including the two production sites of Villingen-Schwenningen (Germany) and Gaffney (USA). The traditional VULKAN brand, whose roots go back to 1898, is a pioneer in LED lighting for streets, junctions, parking lots, pedestrian zones and public facilities.

  • The Ragni group is now a team of 400 specialists offering services to ensure the development, and manufacturing of public lighting products and smart city solutions for international markets.

  • This acquisition helps Ragni into their international development, as their first acquisition outside of France. The leading position of Ragni within the French territory and the leading position of Hess GmbH in Germany and in Europe will strengthens the company’s position in the European street lighting market, particularly in the DACH region (Germany, Austria, Switzerland)

  • The Ragni group, run by the eponymous family, has a long history of commitment to innovation and quality in the field of street lighting, with an expected Turnover of nearly €100 million for 2023. With its strong family values, the group shares with Hess a common passion for excellence, innovation, and customer satisfaction.

A transaction supported by Altios Corporate Finance

  • Altios Corporate Finance advised Ragni on the transaction for the purchase of Hess GmbH Licht + Form.
  • The mandate consisted in valuing and analyzing the financial situation of the Hess GmbH Licht + Form, then assisting with the negotiation phase (LOI), coordinating due diligence and contractual documents (SPA, Supply Agreement, IP Agreement) in cooperation with the sellers’ advisors, in accordance with the parties’ agreements and the requirements of German law.
  • The role of Altios Corporate Finance:
    > Financial analysis and valuation of the target company
    > Support in negotiating LOI, SPA & other contractual documents
    > Due diligence coordination

Testimony of Ragni SAS

We had the opportunity to meet the ALTIOS team who presented the portfolio of their knowledge for accompanying our company in the M&A process, we have been extremely happy to collaborate, the team was dedicated, the management of the project has been handled in a perfect way to let us work on what was our expertise, we will definitively have the opportunity to collaborate again!

Jean-Christophe Ragni, General Manager at Ragni Group

Testimony of Altios Corporate Finance

We are pleased to have concluded this first international acquisition for Ragni. The acquisition of Hess, one of the historical German brands in lighting solutions will enable the group to become the European leader in its sector. The start of a successful international expansion, to be continued!

Alexandre Kaplan, M&A Director at Altios Corporate Finance

Participants

Buyer’s advisors:
Altios Corporate Finance (M&A) : Alexandre Kaplan and Camille Garbolino
➢ LPA (Legal) : Dr. Leif Gösta Gerlin, Dr. Steffen Paulmann, Matthias Krämer and Björn Joachim
➢ PwC (Financial) : Sinan Kücükakyüz, Fabio Lorenzo Recupero, Marc Klusch and Matthias Bühler (PWC Transaction Services GmbH)

Sellers’ advisors:
➢ Carlsquare (M&A) : Griffin Steele and Christoph Margotti
➢ Deloitte (Legal) : Marcus C. Spangenberger, Dirk Haenisch and Frank Tschentscher

Contact Press: Alexandre Kaplan, M&A Director, a.kaplan@altios.com

South East Asian Forum

South East Asian Forum - Illustration

December 4th, 2023

At the crossroads of the Indo-Pacific region, the Association of Southeast Asian Nations is today one of the main drivers of worldwide growth. The latter is being triggered by its domestic spending (670 million inhabitants), its industry (textile, electronics, the automotive sector…), and its opening up to international business.

Willing to promote the South East Asian region, the backbone of the Indo-Pacific region and source of worldwide growth, Business France is organizing for the first time in 5 years, in partnership with the French Senate, an economic forum on the South East Asian zone, on December 4th, 2023.

Only companies interested by the French products and services, or interested in creating partnership will be able to access to the event.
Any company aiming to sell or export products or services to French companies will be declined.

Here is the program of the South East Asian Forum:

8:15 –

8:45 –

9:20 –

10:10 –


10:55 –

11:45 –

12:25 –

13:45 –

14:45 –


15:30 –

15:45 to 19:00 –

Coffee and Greetings

Opening speeches

New economic trends and current business climate

Environmental risks and energy mix: the urgency of industry decarbonation

Agriculture and food security issues: more than 650 M people to feed

Uneven health systems: from chronic diseases to an ageing population

Networking Lunch

Colossal transport and logistic infrastructure needs

Innovation and e-solutions: key stimuli for growth and consumption in the South East Asian region

Closing remarks

B2B One-to-one Meetings

Are you interested in this forum?

Only companies interested by the French products and services, or interested in creating partnership will be able to access to the event.
Any company aiming to sell or export products or services to French companies will be declined.